Amgen pledges to launch Eylea biosim after legal win—but Regeneron stresses the fight’s not over yet
October 23, 2024Roche CEO says Novo’s Catalent buyout ‘could be a problem’ for smaller drugmakers
October 23, 2024Roche’s Vabysmo will rise above Eylea biosim threat, exec says, as DMD gene therapy Elevidys delivers sales surprise
aliu
Wed, 10/23/2024 – 10:54
